Eledon Pharmaceuticals, Inc.
ELDN
Price:
$4.01
Market Cap:
$239.55M
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical trials for the treatment of ALS, and Phase 2 clinical trials in islet cell transplantation for the treatment of type 1 diabetes. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2...[Read more]
Industry
Biotechnology
IPO Date
2014-09-17
Stock Exchange
NASDAQ
Ticker
ELDN
PE Ratio
[5.49]
ROE
[21.51%]
Current Ratio
[6.53]
Dividend Yield
[0%]
Enterprise Value
[233.30M]
Dividend History
The ROE as of November 2024 (TTM) for Eledon Pharmaceuticals, Inc. (ELDN) is 21.51%
According to Eledon Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 21.51%. This represents a change of -85.76% compared to the average of 151.04% of the last 4 quarters.
Eledon Pharmaceuticals, Inc. (ELDN) Historical ROE (quarterly & annually)
How has ELDN ROE performed in the past?
The mean historical ROE of Eledon Pharmaceuticals, Inc. over the last ten years is -128.67%. The current 21.51% ROE has changed -116.72% with respect to the historical average. Over the past ten years (40 quarters), ELDN's ROE was at its highest in in the June 2024 quarter at 528.26%. The ROE was at its lowest in in the March 2020 quarter at -69.62%.
Average
-128.67%
Median
-85.05%
Minimum
-559.46%
Maximum
-11.97%
Eledon Pharmaceuticals, Inc. (ELDN) ROE by Quarter and Year
Discovering the peaks and valleys of Eledon Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 438.23%
Maximum Annual ROE = -11.97%
Minimum Annual Increase = -179.11%
Minimum Annual ROE = -559.46%
| Year | ROE | Change |
|---|---|---|
| 2023 | -559.46% | 438.23% |
| 2022 | -103.94% | 394.01% |
| 2021 | -21.04% | 75.81% |
| 2020 | -11.97% | -93.66% |
| 2019 | -188.89% | 94.62% |
| 2018 | -97.05% | 43.94% |
| 2017 | -67.43% | -52.29% |
| 2016 | -141.33% | 93.48% |
| 2015 | -73.05% | 224.53% |
| 2014 | -22.51% | -179.11% |
Eledon Pharmaceuticals, Inc. (ELDN) Average ROE
How has ELDN ROE performed in the past?
The current ROE of Eledon Pharmaceuticals, Inc. (ELDN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-228.15%
5-year avg
-177.06%
10-year avg
-128.67%
Eledon Pharmaceuticals, Inc. (ELDN) ROE vs. Peers
How is ELDN’s ROE compared to its peers?
Eledon Pharmaceuticals, Inc.’s ROE is greater than Inozyme Pharma, Inc. (-88.42%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than Terns Pharmaceuticals, Inc. (-32.76%), greater than HOOKIPA Pharma Inc. (-49.25%), greater than X4 Pharmaceuticals, Inc. (-32.51%), greater than Acumen Pharmaceuticals, Inc. (-32.99%), greater than Amylyx Pharmaceuticals, Inc. (-85.39%), greater than Mereo BioPharma Group plc (-69.11%),
| Company | ROE | Market cap |
|---|---|---|
| -88.42% | $180.51M | |
| -22.40% | $1.38B | |
| -32.76% | $491.80M | |
| -49.25% | $20.76M | |
| -32.51% | $57.64M | |
| -32.99% | $142.39M | |
| -85.39% | $361.25M | |
| -69.11% | $575.61M |
Build a custom stock screener for Eledon Pharmaceuticals, Inc. (ELDN) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eledon Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Eledon Pharmaceuticals, Inc. (ELDN) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Eledon Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Eledon Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Eledon Pharmaceuticals, Inc. (ELDN)?
What is the highest ROE for Eledon Pharmaceuticals, Inc. (ELDN)?
What is the 3-year average ROE for Eledon Pharmaceuticals, Inc. (ELDN)?
What is the 5-year average ROE for Eledon Pharmaceuticals, Inc. (ELDN)?
How does the current ROE for Eledon Pharmaceuticals, Inc. (ELDN) compare to its historical average?